In vivo studies using mouse models of LPS-induced sepsis confirmed that fucoxanthin decreases the levels of inflammatory cytokines like IL-6 and IL-1β by regulating the NF-κB signaling pathway, thus suggesting its therapeutic potential against sepsis and acute inflammation [86]. Here, IL1B is linked to Sepsis.